AJ Jacobs, J Mongkolsapaya, GR Screaton… - Tuberculosis, 2016 - Elsevier
Tuberculosis (TB) remains a major public health problem internationally, causing 9.6 million new cases and 1.5 million deaths worldwide in 2014. The Bacillus Calmette-Guérin vaccine …
Macrophages, the major host cells harboring Mycobacterium tuberculosis (M. tb), are a heterogeneous cell type depending on their tissue of origin and host they are derived from …
E Iizasa, Y Chuma, T Uematsu, M Kubota… - Nature …, 2021 - nature.com
Mycobacterial cell-wall glycolipids elicit an anti-mycobacterial immune response via FcRγ- associated C-type lectin receptors, including Mincle, and caspase-recruitment domain family …
Immunometabolism, the study of the relationship between bioenergetic pathways and specific functions of immune cells, has recently gained increasing appreciation. In response …
Despite some major progress made in developing tuberculosis (TB) vaccine strategies, with a dozen novel vaccines currently in the clinical pipeline, the world is still missing an effective …
Abstract The interleukin-10 (IL-10) family of cytokines consists of six immune mediators, namely IL-10, IL-19, IL-20, IL-22, IL-24 and IL-26. IL-10, IL-22, IL-24 and IL-26 are critical for …
L Moreira-Teixeira, PS Redford… - The Journal of …, 2017 - journals.aai.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis infection, is a leading cause of mortality and morbidity, causing∼ 1.5 million deaths annually. CD4+ T cells and several …
Mycobacterium tuberculosis, the causative agent of pulmonary tuberculosis (TB), is responsible for millions of infections and deaths annually. Decades of TB vaccine …
The World Health Organization (WHO) herald of the “End TB Strategy” has defined goals and targets for tuberculosis prevention, care, and control to end the global tuberculosis …